Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 as the page's version marker, indicating a small update to the site's code or content management. No changes to the study details, eligibility criteria, or results are introduced.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.6.5 appears, replacing Revision: v3.6.4. This indicates a newer build of the page without changes to the study information.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision tag updated to v3.6.4 on the page, reflecting a deployment-level change from the previous revision.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an update to the page's revision label.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page shows a new revision label (v3.6.2) replacing the previous v3.6.0, indicating a minor update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check90 days agoChange DetectedNew sections provide guidance on reading the study record and joining the study. The recruitment status now indicates that no participants are being sought, and the Intervention/Treatment heading formatting has been adjusted.SummaryDifference0.5%

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.